News :
October 01 2012
Grenoble Institute of Technology gains ground
- Education
- Life @ MINATEC
- News
The new Grenoble Institute of Technology management team is continuing to implement the campus expansion plan established by the outgoing management team. As the largest higher education establishment in Grenoble’s Presqu’ile scientific district, the school aims to expand its presence in this research hub—of which MINATEC is a key player. By September 2014 Phelma engineering […] >>
October 01 2012
Breakthrough in measuring nanostructure dopant energy spectra
- MINATEC
- News
- Research
One of the key challenges of nanoelectronics is measuring dopant energy spectra in silicon nanostructures, because at this scale energy levels depend largely on the surrounding environment—and the in situ measurement of a single dopant is extremely difficult. However an INAC-Leti team of researchers seem to have found a way to overcome this hurdle. They […] >>
October 01 2012
The CEA-Magillem joint lab presents its research
- Industry
- MINATEC
- News
Whereas most MINATEC joint labs tend to avoid the spotlight, the MINATEC-Magillem (a provider of electronic documentation systems) lab decided to hold a presentation day packed with exhibits, demonstrations, and panel discussions. Some 40 people from companies like STMicroelectronics, Schneider Electric, Thales, and Alstom attended the event to learn more about the lab’s research. These […] >>
October 01 2012
CBRAM that lasts 10 years at 120°C
- MINATEC
- News
- Research
Despite its many advantages—it is fast, energy efficient, and easy to integrate—conductive-bridging RAM (CBRAM) technology has one weak spot: it can’t store data at very high temperatures. That’s why Leti researchers have teamed up with Altis Semiconductor to develop new materials and new electrolyte and electrode stacking methods. Thanks to these breakthroughs, the research partners […] >>
October 01 2012
Better treatment for breast cancer relapses
- MINATEC
- News
- Research
Thanks to Lymphodivpenia, a biomarker developed by Grenoble-based ImmunID, doctors can offer more targeted treatment to metastatic breast cancer patients suffering from a relapse. This is the main conclusion of research published in Oncoimmunology in July 2012, and confirms the findings of two previous studies. A total of 133 patients have been tracked so far. […] >>